Opinion
Accepted on 09 Jun 2025
Type 2 MI a legitimate Efficacy Endpoint in Cardiovascular Trials? A Critical Appraisal
in Cardiovascular Epidemiology and Prevention
Opinion
Accepted on 09 Jun 2025
in Cardiovascular Epidemiology and Prevention
Original Research
Accepted on 09 Jun 2025
in Pediatric Cardiology
Original Research
Accepted on 09 Jun 2025
in Gastroenterology
Original Research
Accepted on 09 Jun 2025
in Nutrition and Microbes
Original Research
Accepted on 09 Jun 2025
in Cancer Metabolism
Original Research
Accepted on 09 Jun 2025
in Pediatric Dentistry
Original Research
Accepted on 09 Jun 2025
in Children and Health
Original Research
Accepted on 09 Jun 2025
in Pediatric Endocrinology
Original Research
Accepted on 09 Jun 2025
in Green and Sustainable Chemistry
Original Research
Accepted on 09 Jun 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 09 Jun 2025
in Virtual Reality and Human Behaviour
Original Research
Accepted on 09 Jun 2025
in Gynecological Oncology
Original Research
Accepted on 09 Jun 2025
in Clinical Diabetes
Editorial
Accepted on 09 Jun 2025
in Systems Integration
Original Research
Accepted on 09 Jun 2025
in Clinical Diabetes
Original Research
Accepted on 09 Jun 2025
in Molecular and Cellular Oncology